Financial Performance - The company's operating revenue for Q1 2025 was ¥331,971,798.59, a decrease of 7.26% compared to ¥357,946,698.78 in the same period last year[5] - Net profit attributable to shareholders was ¥4,214,426.49, down 72.47% from ¥15,307,127.61 year-on-year[5] - The net cash flow from operating activities decreased by 25.10% to ¥17,672,976.99 from ¥23,595,222.41 in the previous year[5] - Basic earnings per share fell to ¥0.0137, a decline of 72.55% compared to ¥0.0499 in the same period last year[5] - Operating profit for Q1 2025 was ¥4,196,550.96, representing a 74.42% decrease from ¥16,405,164.92 in the same period last year[9] - Net profit for the period was ¥4,756,833.60, down from ¥16,458,350.43, representing a decline of approximately 71.1% year-over-year[22] - Earnings per share (EPS) decreased to ¥0.0137 from ¥0.0499, a decline of approximately 72.5% year-over-year[23] Asset and Liability Overview - Total assets at the end of the reporting period were ¥1,502,990,227.96, reflecting a slight increase of 0.67% from ¥1,493,054,317.26 at the end of the previous year[5] - The total assets of the company as of March 31, 2025, amounted to CNY 1,502,990,227.96, an increase from CNY 1,493,054,317.26 at the beginning of the period[17] - The company's current assets decreased from CNY 351,917,188.66 to CNY 318,400,533.38 during the same period[17] - The company's non-current assets increased from CNY 1,141,137,128.60 to CNY 1,184,589,694.58[18] - The total liabilities decreased from CNY 464,256,008.53 to CNY 429,412,522.12, indicating improved financial health[18] - Total liabilities increased slightly to ¥628,645,131.92 from ¥623,466,054.82, an increase of approximately 0.3% year-over-year[19] - Total equity attributable to shareholders increased to ¥843,026,888.16 from ¥838,812,461.67, an increase of about 0.5% year-over-year[19] Investment and Cash Flow - The company reported a significant decrease in investment income, which was ¥4,380,195.34, down 52.09% from ¥9,142,822.31 year-on-year[9] - Cash received from investment activities increased by 48.91% to ¥60,098,921.46 compared to ¥40,360,079.93 in the previous year[10] - Operating cash flow net amount decreased to ¥17,672,976.99 from ¥23,595,222.41, a decrease of about 25.3% year-over-year[24] - Net cash inflow from investment activities was $60,107,234.73, an increase from $40,371,961.35 year-over-year[25] - Cash outflow for investment activities totaled $56,323,708.02, compared to $36,924,147.52 in the previous period[25] - Net cash flow from investment activities was $3,783,526.71, up from $3,447,813.83 year-over-year[25] - Cash inflow from financing activities was $600,000.00, with no previous cash inflow reported[25] - Cash outflow for financing activities was $14,903,114.75, down from $20,716,426.56 year-over-year[25] - Net cash flow from financing activities was -$14,303,114.75, compared to -$20,716,426.56 in the previous period[25] - The net increase in cash and cash equivalents was $7,153,388.95, compared to $6,326,609.68 year-over-year[25] - The ending balance of cash and cash equivalents was $111,647,725.99, up from $95,407,521.93 in the previous period[25] Operational Developments - The company aims to overcome challenges in the restaurant industry, targeting a goal for 2025 while enhancing operational analysis and innovation[14] - During the Spring Festival, the company saw a 12% increase in table reservations and an 11% increase in customer visits at its Beijing locations compared to the previous year[14] - Sales of New Year’s Eve dinner packages increased by 26.3% year-on-year, reflecting strong demand for festive offerings[14] - The company opened three new model Meituan satellite stores, expanding its market presence[14] - The company launched multiple new products, including the "仿膳茶社" pastry gift box and "金玉满堂" food products, which received positive consumer feedback[15] - The company is actively engaging in online sales through platforms like Douyin and has seen growth in fan engagement and sales performance[15] Research and Development - Research and development expenses increased to ¥945,096.00 from ¥841,213.69, reflecting an increase of approximately 12.3% year-over-year[21]
全聚德(002186) - 2025 Q1 - 季度财报